Q3 2018: WRAPPING UP FUNDRAISING, BUILDING THE PORTFOLIO, AND DOUBLING DOWN ON OUR INVESTMENT THESIS

Q3 has been filled with good fortune for Jumpstart Capital. In our quarterly installment, we share the latest results in our efforts to round out the Fund while simultaneously deploying capital into multiple disruptive companies.

We’re delighted that the Fund is ~65% subscribed and right on schedule. Learn more in this update about how several significant partnership opportunities may take us beyond expectations in Q4.

We’ve taken positions in two additional companies: SimplifyASC is a cloud-based clinical and practice management software solution for the underserved ambulatory surgery center (ASC) market. We led the Series A, joined the board, and are hands-on supporting the success of this innovative Nashville-based company. We also joined other world-class investors in a Series C round for higi, based in Chicago. Higi has 11,000 health ‘stations’ nationwide in well-known retail pharmacies and they’re creating a new ‘front door’ for primary care—a true population health enablement solution with a terrific opportunity to help millions of people. We hope you’ll echo our enthusiasm when you read more about SimplifyASC and higi below.

Highlights from the 2018 Health:Further event along with major events in the healthcare provider, payer, and consumer markets in the last three months have made us more bullish on our investment thesis than ever. Inside, you’ll learn more about the continued developments of strange bedfellows in the healthcare landscape and the rising empowerment of the consumer as decision-maker. We thank each of you for taking this journey with us.